First of all, it's completely understandable to feel scared right now. A new diagnosis like this brings up so many emotions, and worrying about time is one of the most natural responses. You are not alone in feeling this way.
The good news is that treatments for HR+ metastatic breast cancer have improved significantly, and Show Full Answer
First of all, it's completely understandable to feel scared right now. A new diagnosis like this brings up so many emotions, and worrying about time is one of the most natural responses. You are not alone in feeling this way.
The good news is that treatments for HR+ metastatic breast cancer have improved significantly, and the combination you're on — anastrozole with ribociclib (a CDK4/6 inhibitor) — is actually one of the recommended approaches for HR+ metastatic breast cancer. This combination has been shown to:
- Slow down cancer progression
- Improve survival rates
- Help keep cancer stable for longer periods Survival statistics can feel frightening to read, but it's really important to remember that they are based on older data and don't reflect the newer, more effective treatments available today — like the one you're already on.
Many people are now living 10 or more years after a metastatic breast cancer diagnosis. The goal of treatment is to keep cancer stable for as long as possible while maintaining quality of life. There are also newer therapies emerging all the time. For example, if your cancer carries a PIK3CA mutation, newer targeted treatments are showing very promising results in extending survival further.
The most important thing right now is to lean on your care team, ask questions, and know that starting treatment quickly — which you've already done — is a really positive step. 💙
June 20
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
